✦ LIBER ✦

Switch from abciximab to eptifibatide during percutaneous coronary intervention

✍ Scribed by Magnus Wahlin; Per Albertsson; Thomas Karlsson; Göran Matejka; Annika Odell; Farshad Tahmasebiepour; Christina Wolmeryd; Lars Grip

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Results Following Switch From

✍ Michael Koutouzis; Bo Lagerqvist; Jonas Oldgren; Axel Åkerblom; Magnus Wahlin; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

Long-term mortality after bolus-only adm

✍ Jonathan D. Marmur; Shyam Poludasu; Jason Lazar; Erdal Cavusoglu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Eptifibatide Is Noninferior to Abciximab

✍ Axel Åkerblom; Stefan K. James; Michail Koutouzis; Bo Lagerqvist; Ulf Stenestran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Comparison of Catheterization Laboratory

✍ Ajay J. Kirtane; Helen Parise; Roxana Mehran; Jeffrey W. Moses; Martin Fahy; Mic 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Effectiveness of tirofiban, eptifibatide

✍ Annapoorna S Kini; Merwin Richard; Javed Suleman; Nohelia Perez; Paul Lee; Edwar 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Dalteparin in combination with abciximab

✍ Dean J. Kereiakes; Neal S. Kleiman; Edward Fry; Grace Mwawasi; Rose Lengerich; K 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 100 KB